Asphyxia Market Summary

• According to DelveInsight, Asphyxia Market is expected to grow at a decent CAGR by 2032.
• Key Asphyxia Companies are Pharmazz, Inc., ReAlta Life Sciences, Acer Therapeutics, and others

Factors Affecting Asphyxia Market Growth

• Rising incidence of birth asphyxia, respiratory disorders, and emergency medical conditions
• Growing awareness of early diagnosis and timely intervention
• Advancements in medical devices such as ventilators, oxygen therapy systems, and monitoring tools
• Expansion of neonatal and emergency care infrastructure
• Increasing healthcare expenditure and government initiatives to reduce asphyxia-related mortality
• Availability of trained healthcare professionals and emergency response systems
• High cost of advanced treatment devices and limited reimbursement in some regions
• Uneven access to healthcare facilities in low- and middle-income countries
• Stringent regulatory requirements for medical devices and therapies
• Ethical, legal, and long-term care considerations associated with severe asphyxia outcomes

DelveInsight's "Asphyxia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Asphyxia, historical and forecasted epidemiology as well as the Asphyxia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Asphyxia market report provides current treatment practices, emerging drugs, Asphyxia market share of the individual therapies, current and forecasted Asphyxia market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Asphyxia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Asphyxia market.

Asphyxia Disease Understanding

Asphyxia is a life-threatening condition that occurs when the body is deprived of adequate oxygen, leading to impaired cellular function and potential organ failure. It can result from airway obstruction, respiratory failure, environmental oxygen deficiency, or interference with oxygen transport in the blood. If not promptly managed, asphyxia can cause irreversible brain damage or death.

Asphyxia Overview

Asphyxia may be acute or chronic and can occur in various settings, including choking, drowning, strangulation, suffocation, inhalation of toxic gases (such as carbon monoxide), severe asthma attacks, or neuromuscular disorders affecting breathing. In newborns, birth asphyxia occurs when oxygen supply to the infant is compromised before, during, or immediately after delivery.

Common signs and symptoms include shortness of breath, cyanosis (bluish discoloration of skin or lips), confusion, agitation, loss of consciousness, and cardiac arrest in severe cases. The severity and outcome depend on the duration and degree of oxygen deprivation.

Asphyxia Diagnosis

Diagnosis of asphyxia is primarily clinical and requires rapid assessment. Initial evaluation includes checking airway patency, breathing, circulation, oxygen saturation, and level of consciousness. Pulse oximetry is used to assess oxygen levels, while arterial blood gas analysis helps determine hypoxemia, hypercapnia, and acid–base status.

Additional diagnostic tools may include chest X-ray, CT scan, or bronchoscopy to identify airway obstruction or lung pathology. In suspected toxic exposures, blood tests for substances such as carboxyhemoglobin (in carbon monoxide poisoning) are performed. In neonatal asphyxia, diagnosis is supported by Apgar scores, umbilical cord blood gas analysis, and evidence of organ dysfunction.

Asphyxia Treatment

Treatment of asphyxia focuses on immediate restoration of oxygenation and ventilation. The first priority is securing the airway by removing obstructions, positioning the patient properly, or performing endotracheal intubation if necessary. Supplemental oxygen is administered promptly, and mechanical ventilation may be required in severe cases.

Supportive measures include cardiopulmonary resuscitation (CPR) if cardiac arrest occurs, intravenous fluids to maintain circulation, and medications as indicated based on the underlying cause. In cases of poisoning, specific antidotes or hyperbaric oxygen therapy may be required. For neonatal asphyxia, therapeutic hypothermia may be used to reduce the risk of neurological damage.

Asphyxia Prognosis

The outcome of asphyxia depends on the duration of oxygen deprivation, speed of intervention, and patient health status. Early recognition and prompt treatment significantly improve survival and neurological outcomes, while delayed management increases the risk of permanent organ damage or death.

Asphyxia Epidemiology 

The Asphyxia epidemiology section provides insights about the historical and current Asphyxia patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Asphyxia market report also provides the diagnosed patient pool and their trends along with assumptions undertaken. 

Key Findings from Asphyxia Epidemiological Analyses and Forecast

The Asphyxia epidemiology covered in the report provides historical as well as forecasted Asphyxia epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

Country Wise- Asphyxia Epidemiology

The epidemiology segment also provides the Asphyxia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Asphyxia Drugs Analysis

The drug chapter segment of the Asphyxia market report encloses the detailed analysis of Asphyxia marketed drugs and late-stage (Phase-III and Phase-II) Asphyxia pipeline drugs. It also helps to understand the Asphyxia clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Asphyxia Marketed Drugs

The Asphyxia market report provides the details of the marketed products/off-label treatments available for Asphyxia treatment.

Asphyxia Emerging Drugs

The Asphyxia market report provides the details of the emerging therapies under the late and mid-stage of development for Asphyxia treatment.

Asphyxia Market Outlook

The Asphyxia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Asphyxia market trends by analyzing the impact of current Asphyxia therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Asphyxia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Asphyxia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Asphyxia market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Findings from Asphyxia Market Report

This section includes a glimpse of the Asphyxia market in 7MM.

Asphyxia Regional Analysis

The United States Asphyxia Market Outlook

This section provides the total Asphyxia market size and market size by therapies in the United States.

EU-5 Countries Asphyxia Market Outlook

The total Asphyxia market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Asphyxia Market Outlook

The total Asphyxia market size and market size by therapies in Japan is also mentioned.

Asphyxia Market Recent Developments and Breakthroughs

Recent updates on clinical trials for asphyxia have highlighted significant progress in addressing this critical condition. ReAlta Life Sciences initiated a Phase II trial on August 2, 2023, to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of RLS-0071 in newborns with hypoxic-ischemic encephalopathy (HIE), commonly known as birth asphyxia. This two-stage, multiple-ascending dose, placebo-controlled, randomized, double-blind study aims to provide new insights into effective treatments for newborns affected by this condition.

Additionally, a randomized clinical trial by the HEAL Consortium published in the New England Journal of Medicine on January 12, 2022, investigated the use of erythropoietin for hypoxic-ischemic encephalopathy. This trial focused on improving outcomes for infants affected by birth asphyxia, offering valuable information for future therapeutic approaches. These advancements in clinical trials underscore the ongoing efforts to better understand and manage asphyxia, ultimately aiming to enhance outcomes for those affected by this condition.

Asphyxia Drugs Uptake

This section focuses on the rate of uptake of the potential Asphyxia drugs recently launched in the Asphyxia market or expected to get launched in the market during the study period 2019-2032. The analysis covers Asphyxia market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Asphyxia Drugs Uptake helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs, and allow the comparison of the drugs on the basis of Asphyxia market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Asphyxia Clinical Trial Activities

The Asphyxia market report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Asphyxia key players involved in developing targeted therapeutics.

Asphyxia Pipeline Development Activities

The Asphyxia market report covers the detailed information of collaborations, acquisition, and merger, licensing, patent details, and other information for Asphyxia emerging therapies.

Reimbursement Scenario in Asphyxia

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

Latest KOL- Views on Asphyxia

To keep up with current Asphyxia market trends, we take KOLs and SMEs ' opinion working in the Asphyxia domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Asphyxia market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Asphyxia Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Asphyxia Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Asphyxia Market Report

• The Asphyxia market report covers the descriptive overview of Asphyxia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Asphyxia epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Asphyxia is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of the Asphyxia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The Asphyxia market report provides an edge while developing business strategies, by understanding trends shaping and driving the global Asphyxia market

Asphyxia Market Report Highlights

• In the coming years, the Asphyxia market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Asphyxia R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
• Major players are involved in developing therapies for Asphyxia. The launch of emerging therapies will significantly impact the Asphyxia market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Asphyxia
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Asphyxia Market Report Insights

• Asphyxia Patient Population
• Therapeutic Approaches
• Asphyxia Pipeline Analysis
• Asphyxia Market Size
• Asphyxia Market Trends
• Asphyxia Market Opportunities
• Impact of upcoming Asphyxia Therapies

Asphyxia Market Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Asphyxia Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Asphyxia Market
• Asphyxia Drugs Uptake

Asphyxia Market Report Assessment

• Current Treatment Practices
• Unmet Needs
• Asphyxia Pipeline Product Profiles
• Asphyxia Market Attractiveness
• Asphyxia Market Drivers
• Asphyxia Market Barriers

Key Questions Answered from Asphyxia Market Report

Asphyxia Market Insights

• What was the Asphyxia drug class share (%) distribution in 2019 and how it would look like in 2032?
• What would be the Asphyxia market size as well as market size by therapies across the 7MM during the forecast period (2019-2032)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Asphyxia market size during the forecast period (2019-2032)?
• At what CAGR, the Asphyxia market is expected to grow by 7MM during the forecast period (2019-2032)?
• What would be the Asphyxia market outlook across the 7MM during the forecast period (2019-2032)?
• What would be the Asphyxia market growth till 2032, and what will be the resultant market Size in the year 2032?
• How would the unmet needs affect the Asphyxia market dynamics and subsequent analysis of the associated trends?

Asphyxia Epidemiology Insights

• What are the disease risk, burden, and regional/ethnic differences of the Asphyxia?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What is the historical Asphyxia patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Asphyxia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• Where will be the growth opportunities in the 7MM with respect to the patient population pertaining to Asphyxia?
• Out of all 7MM countries, which country would have the highest prevalent population of Asphyxia during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

• What are the current options for the Asphyxia treatment in addition to the approved therapies?
• What are the current treatment guidelines for the treatment of Asphyxia in the USA, Europe, and Japan?
• What are the Asphyxia marketed drugs and their respective MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many Asphyxia companies are developing therapies for the treatment of Asphyxia?
• How many Asphyxia therapies are in-development by each company for Asphyxia treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Asphyxia treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Asphyxia therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies being developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Asphyxia and their status?
• What are the current challenges faced in drug development?
• What are the key designations that have been granted for the emerging therapies for Asphyxia?
• What are the global historical and forecasted Asphyxia market?

Reasons to buy the Asphyxia Market Report

• The Asphyxia market report will help in developing business strategies by understanding trends shaping and driving the Asphyxia market
• To understand the future market competition in the Asphyxia market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Asphyxia in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming Asphyxia companies in the  Asphyxia market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Asphyxia market
• To understand the future market competition in the Asphyxia market